| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 8 3971-3980, Copyright © 1993 by American Association of Immunologists
ARTICLES |
MA Gavin, MJ Gilbert, SR Riddell, PD Greenberg and MJ Bevan
Department of Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
The characterization of the epitopes recognized by CTL provides insights into the nature of protective immune responses and facilitates the development of methods to enhance immunity to human pathogens. However, no easily applicable approach for CTL epitope identification has been developed. We present a rapid and efficient method for locating CTL epitopes within a protein. The gene encoding the protein of interest is inserted into an inducible prokaryotic expression vector. Random peptides are then generated by alkali digestion of intact or lysed Escherichia coli expressing the protein and assayed for the presence of the epitope by coating target cells for a standard CTL targeting assay. A large panel of clones containing serial 3'-deletions of the gene is then generated by exonuclease III digestion, and the expressed truncated proteins are similarly analyzed for the presence of the antigenic peptide. The epitope is located by determining the deletion points of clones expressing sequential truncations and differing in Ag expression. This technique was used to identify the H- 2Ld-restricted nonamer in E. coli beta-galactosidase, with residues 876- 884 representing the naturally processed epitope. To test the applicability of this method to other proteins, two genes from human CMV, an often fatal pathogen in immunocompromised individuals, were screened for HLA class I-restricted epitopes. An HLA-B18-restricted epitope from the CMV major immediate-early protein was found to lie between residues 378 and 389, and an HLA-B35-restricted epitope from the CMV pp65 matrix protein was characterized as residues 123 to 131. The results demonstrate that this technique can be used to rapidly identify CTL epitopes within a chosen protein and should be useful for assaying viral isolates or neoplasms for loss of epitopes after mutation and selection by host immune responses.
This article has been cited by other articles:
|
|
 |
|
  S. Delmas, P. Brousset, D. Clement, E. Le Roy, and J.-L. Davignon Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells J. Gen. Virol., September 1, 2007; 88(9): 2441 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Brennan, J. J. Miles, S. L. Silins, M. J. Bell, J. M. Burrows, and S. R. Burrows Predictable {alpha}{beta} T-Cell Receptor Selection toward an HLA-B*3501-Restricted Human Cytomegalovirus Epitope J. Virol., July 1, 2007; 81(13): 7269 - 7273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al. Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation J. Virol., June 1, 2007; 81(11): 5766 - 5776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Gregerson, K. L. Lew, S. W. McPherson, N. D. Heuss, and D. A. Ferrington RPE Cells Resist Bystander Killing by CTLs, but Are Highly Susceptible to Antigen-Dependent CTL Killing Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5385 - 5394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sanakkayala, A. Sokolovska, J. Gulani, H. HogenEsch, N. Sriranganathan, S. M. Boyle, G. G. Schurig, and R. Vemulapalli Induction of Antigen-Specific Th1-Type Immune Responses by Gamma-Irradiated Recombinant Brucella abortus RB51 Clin. Vaccine Immunol., December 1, 2005; 12(12): 1429 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kondo, Y. Akatsuka, K. Kuzushima, K. Tsujimura, S. Asakura, K. Tajima, Y. Kagami, Y. Kodera, M. Tanimoto, Y. Morishima, et al. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles Blood, January 15, 2004; 103(2): 630 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-Y. Kwok, S. Lutjen, S. Soltek, D. Soldati, D. Busch, M. Deckert, and D. Schluter The Induction and Kinetics of Antigen-Specific CD8 T Cells Are Defined by the Stage Specificity and Compartmentalization of the Antigen in Murine Toxoplasmosis J. Immunol., February 15, 2003; 170(4): 1949 - 1957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Allart, J. Lule, B. Serres, T. Jones, J.-L. Davignon, F. Malecaze, and C. Davrinche Impaired Killing of HCMV-Infected Retinal Pigment Epithelial Cells by Anti-pp65 CD8+ Cytotoxic T Cells Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 665 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, N. B. Myers, M. Robinson, T. H. Hansen, and D. R. Lee Polymorphism at Position 97 in MHC Class I Molecules Affects Peptide Specificity, Cell Surface Stability, and Affinity for {beta}2-Microglobulin J. Immunol., September 15, 2002; 169(6): 3105 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kondo, M. S. Topp, H.-P. Kiem, Y. Obata, Y. Morishima, K. Kuzushima, M. Tanimoto, M. Harada, T. Takahashi, and Y. Akatsuka Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells J. Immunol., August 15, 2002; 169(4): 2164 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Saren, S. Pascolo, S. Stevanovic, T. Dumrese, M. Puolakkainen, M. Sarvas, H.-G. Rammensee, and J. M. Vuola Identification of Chlamydia pneumoniae-Derived Mouse CD8 Epitopes Infect. Immun., July 1, 2002; 70(7): 3336 - 3343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Kershaw, C. Hsu, W. Mondesire, L. L. Parker, G. Wang, W. W. Overwijk, R. Lapointe, J. C. Yang, R.-F. Wang, N. P. Restifo, et al. Immunization against Endogenous Retroviral Tumor-associated Antigens Cancer Res., November 1, 2001; 61(21): 7920 - 7924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tong, W. Song, and R. G. Crystal Combined Intratumoral Injection of Bone Marrow-derived Dendritic Cells and Systemic Chemotherapy to Treat Pre-existing Murine Tumors Cancer Res., October 1, 2001; 61(20): 7530 - 7535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kuzushima, N. Hayashi, H. Kimura, and T. Tsurumi Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay Blood, September 15, 2001; 98(6): 1872 - 1881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vaz-Santiago, J. Lule, P. Rohrlich, C. Jacquier, N. Gibert, E. Le Roy, D. Betbeder, J.-L. Davignon, and C. Davrinche Ex Vivo Stimulation and Expansion of both CD4+ and CD8+ T Cells from Peripheral Blood Mononuclear Cells of Human Cytomegalovirus-Seropositive Blood Donors by Using a Soluble Recombinant Chimeric Protein, IE1-pp65 J. Virol., September 1, 2001; 75(17): 7840 - 7847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, I. M. Belyakov, M. A. Derby, J. Wang, L. F. Boyd, J. A. Berzofsky, and D. H. Margulies Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody J. Immunol., July 15, 2001; 167(2): 699 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Tabi, M. Moutaftsi, and L. K. Borysiewicz Human Cytomegalovirus pp65- and Immediate Early 1 Antigen-Specific HLA Class I-Restricted Cytotoxic T Cell Responses Induced by Cross-Presentation of Viral Antigens J. Immunol., May 1, 2001; 166(9): 5695 - 5703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Neumeister, R. Nanan, T. I. Cornu, C. G. K. Lüder, V. ter Meulen, H. Naim, and S. Niewiesk Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway J. Gen. Virol., February 1, 2001; 82(2): 441 - 447. [Abstract] [Full Text]
|
|
|
|
|
|
V. Bronte, E. Apolloni, A. Cabrelle, R. Ronca, P. Serafini, P. Zamboni, N. P. Restifo, and P. Zanovello Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells Blood, December 1, 2000; 96(12): 3838 - 3846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Arrode, C. Boccaccio, J. Lulé, S. Allart, N. Moinard, J.-P. Abastado, A. Alam, and C. Davrinche Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+ T Cells by Dendritic Cells J. Virol., November 1, 2000; 74(21): 10018 - 10024. [Abstract] [Full Text]
|
|
|
|
|
|
C. Retière, V. Prod'homme, B.-M. Imbert-Marcille, M. Bonneville, H. Vié, and M.-M. Hallet Generation of Cytomegalovirus-Specific Human T-Lymphocyte Clones by Using Autologous B-Lymphoblastoid Cells with Stable Expression of pp65 or IE1 Proteins: a Tool To Study the Fine Specificity of the Antiviral Response J. Virol., May 1, 2000; 74(9): 3948 - 3952. [Abstract] [Full Text]
|
|
|
|
|
|
X.-L. Huang, Z. Fan, C. Kalinyak, J. W. Mellors, and C. R. Rinaldo Jr. CD8+ T-Cell Gamma Interferon Production Specific for Human Immunodeficiency Virus Type 1 (HIV-1) in HIV-1-Infected Subjects Clin. Vaccine Immunol., March 1, 2000; 7(2): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Willimsky and T. Blankenstein Interleukin-7/B7.1-encoding Adenoviruses Induce Rejection of Transplanted but not Nontransplanted Tumors Cancer Res., February 1, 2000; 60(3): 685 - 692. [Abstract] [Full Text]
|
|
|
|
|
|
M. Corr, A. von Damm, D. J. Lee, and H. Tighe In Vivo Priming by DNA Injection Occurs Predominantly by Antigen Transfer J. Immunol., November 1, 1999; 163(9): 4721 - 4727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kern, I. P. Surel, N. Faulhaber, C. Frommel, J. Schneider-Mergener, C. Schonemann, P. Reinke, and H.-D. Volk Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited J. Virol., October 1, 1999; 73(10): 8179 - 8184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bronte, D. B. Chappell, E. Apolloni, A. Cabrelle, M. Wang, P. Hwu, and N. P. Restifo Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation J. Immunol., May 15, 1999; 162(10): 5728 - 5737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bronte, M. Wang, W. W. Overwijk, D. R. Surman, F. Pericle, S. A. Rosenberg, and N. P. Restifo Apoptotic Death of CD8+ T Lymphocytes After Immunization: Induction of a Suppressive Population of Mac-1+/Gr-1+ Cells J. Immunol., November 15, 1998; 161(10): 5313 - 5320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Specht, G. Wang, M. T. Do, J. S. Lam, R. E. Royal, M. E. Reeves, S. A. Rosenberg, and P. Hwu Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases J. Exp. Med., October 20, 1997; 186(8): 1213 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Song, H.-L. Kong, H. Carpenter, H. Torii, R. Granstein, S. Rafii, M. A.S. Moore, and R. G. Crystal Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity J. Exp. Med., October 20, 1997; 186(8): 1247 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bronte, M. W. Carroll, T. J. Goletz, M. Wang, W. W. Overwijk, F. Marincola, S. A. Rosenberg, B. Moss, and N. P. Restifo Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine PNAS, April 1, 1997; 94(7): 3183 - 3188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Buschle, W. Schmidt, W. Zauner, K. Mechtler, B. Trska, H. Kirlappos, and M. L. Birnstiel Transloading of tumor antigen-derived peptides into antigen-presenting cells PNAS, April 1, 1997; 94(7): 3256 - 3261. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
